SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-18-006261
Filing Date
2018-06-04
Accepted
2018-06-04 16:30:35
Documents
11
Period of Report
2018-06-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v060418_8kv1.htm 8-K 23623
2 EXHIBIT 99.1 v060418_ex991.htm EX-99.1 17222
3 EXHIBIT 99.2 v060418_ex992.htm EX-99.2 7154
4 IMAGE finaltgtxascoinvestorana000.jpg GRAPHIC 76982
5 IMAGE finaltgtxascoinvestorana001.jpg GRAPHIC 224848
6 IMAGE finaltgtxascoinvestorana002.jpg GRAPHIC 66590
7 IMAGE finaltgtxascoinvestorana003.jpg GRAPHIC 141336
8 IMAGE finaltgtxascoinvestorana004.jpg GRAPHIC 132120
9 IMAGE finaltgtxascoinvestorana005.jpg GRAPHIC 111776
10 IMAGE finaltgtxascoinvestorana006.jpg GRAPHIC 111191
11 IMAGE finaltgtxascoinvestorana007.jpg GRAPHIC 145158
  Complete submission text file 0001654954-18-006261.txt   1441632
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32639 | Film No.: 18878542
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences